Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults

NCT04501705 is registered in ClinicalTrials.gov with Beijing Sanbo Brain Hospital as lead sponsor.

NCT NCT04501705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04501705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults
Lead sponsor
Beijing Sanbo Brain Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 18, 2020
Completion date
August 31, 2025
Enrollment
29 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent atypical/malignant meningioma